Quetiapine 25 mg: The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
Last updated
Summary
Product
Quetiapine 25 mg
Issue
Health products
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Quetiapine |
Quetiapine 25mg |
DIN 02317893 |
Tablet |
Quetiapine fumarate 25 mg |
35217740A |
Issue
The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Wholesalers, Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
| Sivem Pharmaceuticals ULC 4705 Dobrin Street, Montreal QC H4R 2P7 |
Published by
Health Canada
Audience
General public
Industry
Retail
Recall class
Type II
Identification number
RA-64532
Get notified
Receive notifications for new and updated recalls and alerts by category.